💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Aerie Pharmaceuticals, Inc. (AERI)
« Back to company indexAERI Chatter Timeline
Stock Ticker for AERI
Most Active Tweeters for AERI
| User | Tweets |
|---|---|
| @Tickeron | 8 |
| @FlashAlert_me | 8 |
| @stock_titan | 5 |
| @equity_newswire | 4 |
| @EdgarInsider | 4 |
Recent Tweets for AERI
 |
@Tickeron $AERI's 10-day Moving Average moved below its 50-day Moving Average on April 16, 2021. View odds for this and other… https://t.co/55hfmToKz2 May 8th 2021, 4:05pm |
 |
@CSIMarket $AERI #StockMarket #AeriePharmaceuticals released fiscal first quarter of 2021 Revenues on https://t.co/savSNTKlN1:… https://t.co/zww23Ur5k8 May 8th 2021, 5:05am |
 |
@TradeWithAlerts Nice Print for $AERI - Amount: $2,306,520.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 7th 2021, 4:05pm |
 |
@equity_newswire $AERI Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference https://t.co/wzIFjv4LCe May 7th 2021, 5:05am |
|
@TradeWithAlerts Nice Print for $AERI - Amount: $3,429,495.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 6th 2021, 3:05pm |
 |
@SmallCapsDaily $AERI Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference Business Wi… https://t.co/xlwSV2K5Jw May 6th 2021, 2:05pm |
 |
@otcdynamics $AERI Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference https://t.co/LznYVlslAP May 6th 2021, 11:05am |
 |
@FlashAlert_me $AERI [15s. delayed]: Issued Press Release on May 06, 07:30:00: Aerie Pharmaceuticals to Participate in the Bank of… https://t.co/ARRTLLErGg May 6th 2021, 11:05am |
 |
@stock_titan $AERI Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference https://t.co/JPlafPs6aw May 6th 2021, 11:05am |
 |
@EdgarInsider Filing Alert, FORM 10-Q [Quarterly Report] available. $AERI AERIE PHARMACEUTICALS INC https://t.co/eaC4SZQDQg May 6th 2021, 10:05am |
 |
@SiteFocusHQ $AERI Earnings Intelligence Analysis of recent earnings identified Aerie Pharmaceuticals Inc (NASDAQ: AERI ) busine… https://t.co/UmpsQhw281 May 6th 2021, 4:05am |
 |
@SeekingAlpha $AERI - Aerie Pharmaceuticals, Inc. (AERI) CEO Vince Anido on Q1 2021 Results - Earnings Call Transcript.… https://t.co/NS2hQiJwgq May 6th 2021, 4:05am |
|
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $AERI AERIE PHARMACEUTICALS INC https://t.co/g8mv2xnnWp May 5th 2021, 10:05pm |
 |
@MarcJacksonLA $AERI Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update https://t.co/Azx2nOGX6j May 5th 2021, 8:05pm |
|
@otcdynamics $AERI Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update https://t.co/NOcUjgA93E May 5th 2021, 8:05pm |
 |
@glitchbotio RT @MarketCurrents: $AERI - Aerie Pharmaceuticals EPS misses by $0.04, misses on revenue https://t.co/zh2eAUTyPq May 5th 2021, 8:05pm |
 |
@MarketCurrents $AERI - Aerie Pharmaceuticals EPS misses by $0.04, misses on revenue https://t.co/zh2eAUTyPq May 5th 2021, 8:05pm |
 |
@fintel_io $AERI / Aerie Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Results of Operations and Financi… https://t.co/53oE85Hf0F May 5th 2021, 8:05pm |
|
@FlashAlert_me $AERI [15s. delayed] filed form 8-K on May 05, 16:03:40: Item2.02: Results of Operations & Financial Condition https://t.co/XI8qHloegQ May 5th 2021, 8:05pm |
|
@FlashAlert_me $AERI [15s. delayed]: Issued Press Release on May 05, 16:01:00: Aerie Pharmaceuticals Reports First Quarter 2021 Fi… https://t.co/bOTisqDO3V May 5th 2021, 8:05pm |
|
@stock_titan $AERI Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update https://t.co/WC4TqkdU7J May 5th 2021, 8:05pm |
 |
@AccesswireNews $AERI Aerie Pharmaceuticals, Inc. to Host Earnings Call https://t.co/qFoC0UHOzN May 5th 2021, 7:05pm |
 |
@StockPods $AERI Earnings Call Today: 5:00 PM EST Webcast: https://t.co/gNURfqGHhi Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 May 5th 2021, 6:05pm |
|
@Tickeron Aerie Pharmaceuticals Inc to report earnings on August 11, 2021. Earnings per share (EPS) estimate: $-0.67 $AERI… https://t.co/bdSfsSnoV0 May 5th 2021, 8:05am |
 |
@fda_tracker $AERI Phase 2 trial w/est May completion date NCT04498182: https://t.co/GvKjPLO2PM Trial Tracker: https://t.co/aR7q5oJwjn May 4th 2021, 1:05pm |
|
@Tickeron $AERI's 10-day Moving Average broke below its 50-day Moving Average on April 16, 2021. View odds for this and other… https://t.co/5NVlbD9aSg May 4th 2021, 4:05am |
|
@Tickeron $AERI's 10-day Moving Average moved below its 50-day Moving Average on April 16, 2021. View odds for this and other… https://t.co/X8flmdknTR May 3rd 2021, 9:05am |
|
@Tickeron $AERI's 10-day Moving Average moved below its 50-day Moving Average on April 16, 2021. View odds for this and other… https://t.co/6Pct4roXMw May 2nd 2021, 8:05am |
 |
@AmericanBanking Aerie Pharmaceuticals $AERI Coverage Initiated at Needham & Company LLC https://t.co/Rm0SUbaELj #stocks April 30th 2021, 6:04pm |
 |
@stock_positive $AERI - Aerie Pharmaceuticals - Completes Enrollment of its phase 2B Clinical trial of AR – 15512 (TRPM8 Agonist) April 29th 2021, 3:04pm |
|
@SmallCapsDaily $AERI Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthal… https://t.co/XyZcmOnGF0 April 29th 2021, 2:04pm |
|
@MarcJacksonLA $AERI Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophtha… https://t.co/MnUAc50qYG April 29th 2021, 1:04pm |
|
@equity_newswire $AERI Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthal… https://t.co/uTamjAOa47 April 29th 2021, 1:04pm |
 |
@TeamofStockTra $AERI - Aerie Pharma Highlights Completion Of Enrollment In Phase 2b Trial Of AR-15512 Ophthalmic Solution For Trea… https://t.co/2sLu5wWZhe April 29th 2021, 10:04am |
 |
@AkramMSiddique $AERI - Aerie Pharma Highlights Completion Of Enrollment In Phase 2b Trial Of AR-15512 Ophthalmic Solution For Trea… https://t.co/pm1QgpvH0m April 29th 2021, 10:04am |
|
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $AERI AERIE PHARMACEUTICALS INC https://t.co/WXxWxwtTDR April 29th 2021, 10:04am |
|
@FlashAlert_me $AERI [15s. delayed] filed form 8-K on April 29, 06:40:01: Item7.01: Regulation FD https://t.co/TbtZzupLLP April 29th 2021, 10:04am |
|
@FlashAlert_me $AERI [15s. delayed]: Issued Press Release on April 29, 06:30:00: Aerie Pharmaceuticals Completes Enrollment of its… https://t.co/wQji2jta6R April 29th 2021, 10:04am |
 |
@ToothFrank $AERI keep an eye on this one April 29th 2021, 10:04am |
 |
@BioStocks $AERI Completes Enrollment in Phase 2b Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of P… https://t.co/JSBdE5dhxB April 29th 2021, 10:04am |
|
@stock_titan $AERI Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthal… https://t.co/ufunJK1ia8 April 29th 2021, 10:04am |
|
@Tickeron $AERI enters a Downtrend as Momentum Indicator dropped below the 0 level on April 21, 2021. View odds for this and… https://t.co/7RNwj7SIjV April 29th 2021, 4:04am |
|
@equity_newswire $AERI Aerie Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call on Wednesday,… https://t.co/vsmMJJ0mn6 April 28th 2021, 7:04pm |
|
@SmallCapsDaily $AERI Aerie Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call on Wednesday,… https://t.co/3ibsLjhX9j April 28th 2021, 2:04pm |
|
@MarcJacksonLA $AERI Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmolog… https://t.co/qNhViL07tM April 28th 2021, 2:04pm |
|
@equity_newswire $AERI Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmolog… https://t.co/Kibhljo8km April 28th 2021, 1:04pm |
|
@otcdynamics $AERI Aerie Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call on Wednesday,… https://t.co/70ImuwT1EJ April 28th 2021, 11:04am |
|
@FlashAlert_me $AERI [15s. delayed]: Issued Press Release on April 28, 07:30:00: Aerie Pharmaceuticals to Announce First Quarter 2… https://t.co/zlcdfvAE5U April 28th 2021, 11:04am |
|
@stock_titan $AERI Aerie Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call on Wednesday,… https://t.co/EB5b95LBPC April 28th 2021, 11:04am |
|
@otcdynamics $AERI Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmolog… https://t.co/AdYf3tQPTP April 28th 2021, 11:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
